Growth Metrics

Balchem (BCPC) EBITDA Margin (2016 - 2025)

Balchem (BCPC) has disclosed EBITDA Margin for 16 consecutive years, with 19.84% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 7.0% to 19.84% in Q4 2025 year-over-year; TTM through Dec 2025 was 20.18%, a 100.0% increase, with the full-year FY2025 number at 20.18%, up 100.0% from a year prior.
  • EBITDA Margin was 19.84% for Q4 2025 at Balchem, down from 20.4% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 20.4% in Q3 2025 to a low of 13.77% in Q3 2022.
  • A 5-year average of 17.6% and a median of 17.13% in 2024 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: plummeted -267bps in 2022, then soared 520bps in 2023.
  • Balchem's EBITDA Margin stood at 15.87% in 2021, then dropped by -10bps to 14.32% in 2022, then rose by 17bps to 16.76% in 2023, then rose by 18bps to 19.77% in 2024, then grew by 0bps to 19.84% in 2025.
  • Per Business Quant, the three most recent readings for BCPC's EBITDA Margin are 19.84% (Q4 2025), 20.4% (Q3 2025), and 20.14% (Q2 2025).